Kevere Sachet is a nonsteroidal anti-inflammatory and antirheumatic drug. Indications for use - short-term symptomatic treatment of acute pain of mild to moderate severity, such as musculoskeletal pain, dysmenorrhea and toothache.
Warehouse
1 sachet contains 36.9 mg of dexketoprofen trometamol, which is equivalent to 25 mg of dexketoprofen; excipients: sucrose, ammonium glycyrrhizate, neohesperidin dihydrochalcone, colloidal anhydrous silicon dioxide, lemon flavoring.
Contraindication
Hypersensitivity to the active substance or to any other non-steroidal anti-inflammatory drug (NSAID) or to any of the excipients of the drug.
Use in patients in whom substances with a similar mechanism of action, such as acetylsalicylic acid and other NSAIDs, cause attacks of bronchial asthma, bronchospasm, acute rhinitis or lead to the development of nasal polyps, urticaria or angioedema.
Photoallergic or phototoxic reactions are known during treatment with ketoprofen or fibrates.
History of gastrointestinal bleeding or perforation associated with NSAID use.
Active peptic ulcer/gastrointestinal bleeding, history of bleeding, ulceration or perforation in the digestive tract.
Method of application
Depending on the type and intensity of pain, the recommended dose is 25 mg every 8 hours. The daily dose should not exceed 75 mg.
Keiver Sachet is intended only for short-term use, as needed to relieve symptoms.
Application features
Gastrointestinal safety
Gastrointestinal bleeding, ulceration or perforation, in some cases fatal, have been reported with all NSAIDs at various stages of treatment, regardless of the presence of warning symptoms or a history of serious gastrointestinal disease. If gastrointestinal bleeding or ulceration occurs during treatment with Kevesar, the drug should be discontinued.
The risk of gastrointestinal bleeding, ulceration or perforation increases with increasing NSAID dose in patients with a history of ulcer, especially complicated by bleeding or perforation, and in elderly patients.
Kidney safety
Patients with impaired renal function should be prescribed the drug with caution, since the use of NSAIDs may worsen renal function, fluid retention and edema. Given the increased risk of nephrotoxicity, the drug should be prescribed with caution in treatment with diuretics, as well as in patients who may develop hypovolemia. During treatment, the body should receive a sufficient amount of fluid to avoid dehydration, which can lead to increased toxic effects on the kidneys.
Pregnant women
The use of dexketoprofen in the first and second trimesters of pregnancy is possible only in cases of extreme necessity.
Kaver Sachet is contraindicated in the third trimester of pregnancy.
Children
The use of dexketoprofen trometamol granules in children has not been studied, therefore safety and efficacy in children and adolescents have not been established.
Drivers
When using the drug Kaver Sachet, undesirable effects such as dizziness, visual disturbances or drowsiness may occur. In such cases, it is possible to reduce the speed of reactions when driving vehicles or other mechanisms.
Overdose
Symptoms of overdose are unknown. Similar drugs cause disorders of the gastrointestinal tract (vomiting, anorexia, abdominal pain) and the nervous system (drowsiness, vertigo, disorientation, headache).
Side effects
Blood and lymphatic system disorders: neutropenia, thrombocytopenia.
Immune system disorders: anaphylactic reactions, including anaphylactic shock.
From the nervous system: headache, dizziness, drowsiness, paresthesia, fainting.
From the side of the organs of hearing and labyrinth: dizziness, ringing in the ears.
Storage conditions
Does not require any special storage conditions. Keep out of the reach of children.
